Cargando…
10070: MET-02 NON-SMALL-CELL LUNG CANCER WITH SYNCHRONOUS BRAIN METASTASIS IN THE ERA OF MOLECULAR TARGETED DRUGS: TREATMENT OUTCOME AND RISK FACTORS
Brain metastasis is associated with worse prognosis in patients with non-small cell lung cancer (NSCLC). However, recent advances in molecular targeted therapy are rapidly changing the treatment strategy for NSCLC. Here, we conducted a retrospective study to clarify the prognosis and risk factors in...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213197/ http://dx.doi.org/10.1093/noajnl/vdz039.158 |